Orchid Pharma Limited

Bandhan Mutual Fund acquired 776,976 shares of Orchid Pharma, representing a 1.53% stake, for ₹77.78 crore at ₹1001 apiece, marking a new position in the company.

A pharmaceutical manufacturer focused on active pharmaceutical ingredients and finished dosage forms, Orchid Pharma develops and produces medicines for domestic and international markets. The company operates across API manufacturing, formulation development, and new drug research, serving healthcare providers and patients through a vertically integrated approach. Its distinctive strength lies in combining chemical synthesis capabilities with drug discovery efforts to deliver therapeutic solutions across multiple therapeutic areas.

Formerly IDFC Mutual Fund, rebranded after Bandhan Financial Holdings acquired IDFC's AMC in 2023. Manages over Rs 1.5 lakh crore. Known for strong debt and liquid funds, plus well-regarded equity offerings including the IDFC-lineage Sterling Value Fund and Focused Equity Fund. One of the cleaner transitions in Indian AMC ownership history.